Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |